All participants in the study were subjected to testing for particular molecular markers linked with PEComa [6], such as HMB-45 (90.0%), SMA (81.8%), Melan-A (90.9%), vimentin (90.9%), and Desmin (36.3%). This evidence concerns the gene PMEL and neoplasm with perivascular epithelioid cell differentiation.